GlassScriptPhysician profile
Suah Park
NPI 1316563091
$5,159.46
in general payments reported to CMS, 2019-2025
35 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $886 · 2022: $1,163 · 2023: $818 · 2024: $948 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,042 · Long Term Medical Supply Or Device Loan: $49.95 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,042.47 |
| Long Term Medical Supply Or Device Loan | $49.95 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,853.07 | 2021-2025 | |
| Orexo US, INC. | $638.93 | 2021-2025 | Zubsolv |
| Nestle Healthcare Nutrition INC. | $461.21 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $382.79 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.09 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $148.27 | 2021-2024 | Mounjaro |
| Medtronic, INC. | $142.44 | 2022-2024 | Intellis Adaptivestim |
| Glaxosmithkline, LLC. | $101.29 | 2021-2025 | Shingrix, Trelegy Ellipta |
| Amarin Pharma, INC. | $92.42 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.11 | 2021-2023 | |
| Astellas Pharma US INC | $87.56 | 2021 | |
| Phathom Pharmaceuticals, INC. | $85.41 | 2024-2025 | Voquezna |
| Pfizer INC. | $77.60 | 2021-2025 | |
| Amgen INC. | $70.65 | 2024-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $67.91 | 2025 | Freestyle Insulinx, Freestyle Libre 3 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suah Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.